Literature DB >> 7799048

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.

L Harlan1, O Brawley, F Pommerenke, P Wali, B Kramer.   

Abstract

PURPOSE: Prostate cancer is one of the most common cancers in men. Incidence rates increase with age and are substantially higher in black men than white men. This study examines the variations in the use of radical prostatectomy and radiation by geographic area, age, and race.
MATERIALS AND METHODS: Data from the National Cancer Institute's Surveillance, Epidemiology, and End-Results Program (SEER) were used to examine treatment differences. Current treatments generally consist of prostatectomy, radiation, or careful observation for clinically localized or regional disease.
RESULTS: The age-adjusted proportion of men, age 50 and older, who received radical prostatectomy increased sharply between 1984 and 1991, from 11.0% to 32.3% among men with local/regional disease. The choice of treatment varied widely by geographic regions. In 1991, the proportion that received prostatectomy was highest in Utah (47.8%) and lowest in Connecticut (22.5%) among men with localized and regional disease. The increase in radical prostatectomy was not limited to younger men. Although the rates increased for blacks, black men had lower age-adjusted rates of prostatectomy than whites in all years of the study.
CONCLUSION: The SEER data show a clear trend toward more aggressive treatment, especially prostatectomy. However, the proportion of black men who received prostatectomy was substantially lower than that of white men and this disparity does not appear to be changing.

Entities:  

Mesh:

Year:  1995        PMID: 7799048     DOI: 10.1200/JCO.1995.13.1.93

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  37 in total

1.  Patterns of prostate cancer treatment by clinical stage and age.

Authors:  D Meltzer; B Egleston; I Abdalla
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Racial differences in well-being and cancer concerns in prostate cancer patients.

Authors:  Sumedha Chhatre; Alan J Wein; S Bruce Malkowicz; Ravishankar Jayadevappa
Journal:  J Cancer Surviv       Date:  2011-01-28       Impact factor: 4.442

3.  Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.

Authors:  Christina D Mack; William Carpenter; Anne-Marie Meyer; Hanna Sanoff; Til Stürmer
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

4.  Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems.

Authors:  Vincent L Freeman; Ramon Durazo-Arvizu; Ahsan M Arozullah; LaShon C Keys
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

5.  African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.

Authors:  Augustine C Obirieze; Ambria Moten; Delenya Allen; Chiledum A Ahaghotu
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-16

6.  Racial differences in PSA screening interval and stage at diagnosis.

Authors:  William R Carpenter; Daniel L Howard; Yhenneko J Taylor; Louie E Ross; Sara E Wobker; Paul A Godley
Journal:  Cancer Causes Control       Date:  2010-03-24       Impact factor: 2.506

7.  Are HIV-infected men vulnerable to prostate cancer treatment disparities?

Authors:  Adam B Murphy; Ramona Bhatia; Iman K Martin; David A Klein; Courtney M P Hollowell; Yaw Nyame; Elodi Dielubanza; Chad Achenbach; Rick A Kittles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-25       Impact factor: 4.254

8.  Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.

Authors:  Shi-Yi Wang; Rong Wang; James B Yu; Xiaomei Ma; Xiao Xu; Simon P Kim; Pamela R Soulos; Avantika Saraf; Cary P Gross
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

9.  Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Authors:  Maria J Schymura; Amy R Kahn; Robert R German; Mei-Chin Hsieh; Rosemary D Cress; Jack L Finch; John P Fulton; Tiefu Shen; Erik Stuckart
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

10.  Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Askal Ali; Georges Adunlin; Clement K Gwede; Youjie Huang
Journal:  Am J Mens Health       Date:  2013-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.